Key result
Probable mitochondrial myopathy was identified in 5.4% (9/168) of symptomatic deployed military personnel and was associated with younger age and lower BMI.
Why the study?
Following identification of a soldier with probable mitochondrial myopathy presenting with dyspnea after deployment, the study aimed to compare characteristics of symptomatic military deployers with and without probable mitochondrial myopathy diagnosed by CPET criteria.
Can cardiopulmonary exercise testing (CPET) identify probable mitochondrial myopathy in symptomatic military personnel with unexplained dyspnea following deployment?
Cross-Sectional (n=168)
Can cardiopulmonary exercise testing (CPET) identify probable mitochondrial myopathy in symptomatic military personnel with unexplained dyspnea following deployment?
Mitochondrial myopathy may be a cause of unexplained dyspnea and reduced exercise tolerance in previously deployed military personnel, identifiable via CPET with an arterial line.
Answers are grounded in this paper and cite their sources.
May support CPET screening for mitochondrial myopathy in symptomatic deployers; cross-sectional data leaves open causal role and need for prospective validation.
We identified a case of probable mitochondrial myopathy (MM) in a soldier with dyspnea and reduced exercise tolerance through cardiopulmonary exercise testing (CPET) following Southwest Asia (SWA) deployment. Muscle biopsy showed myopathic features. We compared demographic, occupational exposure, and clinical characteristics in symptomatic military deployers with and without probable MM diagnosed by CPET criteria. We evaluated 235 symptomatic military personnel who deployed to SWA and/or Afghanistan between 2010 and 2021. Of these, 168 underwent cycle ergometer maximal CPET with an indwelling arterial line. We defined probable MM based on five CPET criteria: arterial peak exercise lactate >12 mEq/L, anaerobic threshold (AT) ≤50%, maximum oxygen consumption (VO2 max ) <95% predicted, oxygen (O2) pulse percent predicted (pp) at least 10% lower than heart rate pp, and elevated ventilatory equivalent for O2 at end exercise (VE/VO2 ≥ 40). We characterized demographics, smoking status/pack‐years, spirometry, and deployment exposures, and used descriptive statistics to compare findings in those with and without probable MM. We found 9/168 (5.4%) deployers with probable MM. Compared to symptomatic deployers without probable MM, they were younger ( p = 0.0025) and had lower mean BMI ( p = 0.02). They had a higher mean forced expiratory volume (FEV1) pp ( p = 0.02) and mean arterial oxygen partial pressure (PaO2) at maximum exercise ( p = 0.0003). We found no significant differences in smoking status, deployment frequency/duration, or inhalational exposures. Our findings suggest that mitochondrial myopathy may be a cause of dyspnea and reduced exercise tolerance in a subset of previously deployed military personnel. CPET with arterial line may assist with MM diagnosis and management.
No takes yet. Share an insight, caveat, or question.
Onofrei et al. (2023) conducted a cross-sectional in Unexplained dyspnea and reduced exercise tolerance (n=168). Probable mitochondrial myopathy (MM) vs. Symptomatic deployers without probable MM was evaluated on Prevalence of probable mitochondrial myopathy. Probable mitochondrial myopathy was identified in 5.4% (9/168) of symptomatic deployed military personnel and was associated with younger age and lower BMI.
Synapse has enriched 10 related papers. Consider them for comparative context: